1. Home
  2. OCGN vs SLND Comparison

OCGN vs SLND Comparison

Compare OCGN & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • SLND
  • Stock Information
  • Founded
  • OCGN 2013
  • SLND 1900
  • Country
  • OCGN United States
  • SLND United States
  • Employees
  • OCGN N/A
  • SLND N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • SLND Military/Government/Technical
  • Sector
  • OCGN Health Care
  • SLND Industrials
  • Exchange
  • OCGN Nasdaq
  • SLND Nasdaq
  • Market Cap
  • OCGN 189.6M
  • SLND 175.8M
  • IPO Year
  • OCGN N/A
  • SLND N/A
  • Fundamental
  • Price
  • OCGN $0.68
  • SLND $3.17
  • Analyst Decision
  • OCGN Strong Buy
  • SLND Strong Buy
  • Analyst Count
  • OCGN 3
  • SLND 1
  • Target Price
  • OCGN $6.33
  • SLND $5.00
  • AVG Volume (30 Days)
  • OCGN 4.3M
  • SLND 38.8K
  • Earning Date
  • OCGN 05-13-2025
  • SLND 05-12-2025
  • Dividend Yield
  • OCGN N/A
  • SLND N/A
  • EPS Growth
  • OCGN N/A
  • SLND N/A
  • EPS
  • OCGN N/A
  • SLND N/A
  • Revenue
  • OCGN $4,054,999.00
  • SLND $980,179,000.00
  • Revenue This Year
  • OCGN N/A
  • SLND $4.06
  • Revenue Next Year
  • OCGN N/A
  • SLND $7.16
  • P/E Ratio
  • OCGN N/A
  • SLND N/A
  • Revenue Growth
  • OCGN N/A
  • SLND N/A
  • 52 Week Low
  • OCGN $0.52
  • SLND $1.85
  • 52 Week High
  • OCGN $2.06
  • SLND $5.98
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 51.84
  • SLND 51.95
  • Support Level
  • OCGN $0.64
  • SLND $3.01
  • Resistance Level
  • OCGN $0.74
  • SLND $3.32
  • Average True Range (ATR)
  • OCGN 0.07
  • SLND 0.18
  • MACD
  • OCGN 0.00
  • SLND 0.02
  • Stochastic Oscillator
  • OCGN 54.50
  • SLND 76.56

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.

Share on Social Networks: